tiprankstipranks
Thermo Fisher (GB:0R0H)
LSE:0R0H

Thermo Fisher (0R0H) Share Price & Analysis

3 Followers

0R0H Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$416.09 - $602.74
Previous Close$575.78
Volume327.00
Average Volume (3M)21.85K
Market Cap
$219.33B
Enterprise Value$246.28B
Total Cash (Recent Filing)$8.08B
Total Debt (Recent Filing)$34.92B
Price to Earnings (P/E)37.3
Beta0.97
Jul 24, 2024
Next Dividend Ex-DateN/A
Dividend Yield0.25%
Share Statistics
EPS (TTM)15.45
Shares Outstanding381,312,268
10 Day Avg. Volume9,105
30 Day Avg. Volume21,849
Standard Deviation0.06
R-Squared0.08
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-15.78
Price to Sales (P/S)4.64
Price to Cash Flow (P/CF)14.80
P/FCF Ratio14.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.75
Enterprise Value/Gross Profit8.30
Enterprise Value/Ebitda35.63
Forecast
Price Target Upside8.72% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18

Bulls Say, Bears Say

Bulls Say
Earnings PerformanceThermo Fisher Scientific's 1Q results surpassed expectations with an 8% beat on EPS and a raised full-year guidance, highlighting the company's solid financial performance.
Growth ProspectsSentiment in the biopharma sector is on the rise, with Thermo Fisher Scientific poised for improvement after solid 4Q results and successful expansion into biopharma services, setting the stage for potential high-single digit core growth.
Market PositionThermo Fisher Scientific maintains a strong competitive position in the life science tools industry, with analysts reiterating a Buy rating due to the company's potential for market outgrowth and effective capital deployment.
Bears Say
Earnings GuidanceInvestors are somewhat disappointed in TMO's initial 2024 guide, which reflects a slightly lower mid-point for core growth and EPS than previously indicated.
Financial PerformanceLife Sciences Solutions fell ~20% organic, driven by COVID-related declines and a year-over-year decline in bioproduction.
Revenue And EPS OutlookManagement guided revenues to be flat year over year and EPS to be lower than the midpoint of previous estimates.
---

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.48%26.70%19.77%53.06%
19.77% Other Institutional Investors
53.06% Public Companies and
Individual Investors

0R0H FAQ

What was Thermo Fisher’s price range in the past 12 months?
Thermo Fisher lowest share price was $416.09 and its highest was $602.74 in the past 12 months.
    What is Thermo Fisher’s market cap?
    Currently, no data Available
    When is Thermo Fisher’s upcoming earnings report date?
    Thermo Fisher’s upcoming earnings report date is Jul 24, 2024 which is in 88 days.
      How were Thermo Fisher’s earnings last quarter?
      Thermo Fisher released its earnings results on Apr 24, 2024. The company reported $5.11 earnings per share for the quarter, beating the consensus estimate of $4.709 by $0.401.
        Is Thermo Fisher overvalued?
        According to Wall Street analysts Thermo Fisher’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Thermo Fisher pay dividends?
          Thermo Fisher does not currently pay dividends.
          What is Thermo Fisher’s EPS estimate?
          Thermo Fisher’s EPS estimate is $5.12.
            How many shares outstanding does Thermo Fisher have?
            Thermo Fisher has 381,713,870 shares outstanding.
              What happened to Thermo Fisher’s price movement after its last earnings report?
              Thermo Fisher reported an EPS of $5.11 in its last earnings report, beating expectations of $4.709. Following the earnings report the stock price went down -0.097%.
                Which hedge fund is a major shareholder of Thermo Fisher?
                Among the largest hedge funds holding Thermo Fisher’s share is Tci Fund Management Ltd. It holds Thermo Fisher’s shares valued at 2B.
                  ---

                  Company Description

                  Thermo Fisher

                  Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services segments. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
                  ---

                  0R0H Company Deck

                  ---

                  0R0H Earnings Call

                  Q1 2024
                  0:00 / 0:00
                  ---

                  0R0H Revenue Breakdown

                  53.76%53.76%23.28%16.95%10.28%
                  53.76% Laboratory Products and Biopharma Services
                  23.28% Life Sciences Solutions
                  16.95% Analytical Instruments
                  10.28% Specialty Diagnostics
                  tipranks
                  ---

                  0R0H Stock 12 Months Forecast

                  Average Price Target

                  $623.82
                  ▲(8.72% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"454":"$454","663":"$663","506.25":"$506.3","558.5":"$558.5","610.75":"$610.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":662,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$662.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":623.82,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$623.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":540,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$540.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[454,506.25,558.5,610.75,663],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2023","6":"Oct<br/>2023","9":"Jan<br/>2024","12":"Apr<br/>2024","25":"Apr<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,581.61,587.7938461538462,593.9776923076923,600.1615384615385,606.3453846153847,612.5292307692308,618.7130769230769,624.896923076923,631.0807692307692,637.2646153846154,643.4484615384615,649.6323076923077,655.8161538461538,{"y":662,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,581.61,584.8569230769231,588.1038461538461,591.3507692307693,594.5976923076923,597.8446153846154,601.0915384615384,604.3384615384616,607.5853846153847,610.8323076923077,614.0792307692308,617.3261538461539,620.573076923077,{"y":623.82,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,581.61,578.4092307692308,575.2084615384615,572.0076923076923,568.8069230769231,565.6061538461538,562.4053846153846,559.2046153846154,556.0038461538462,552.8030769230769,549.6023076923077,546.4015384615385,543.2007692307692,{"y":540,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":569.821,"date":1682035200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":544.221,"date":1683244800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":520.558,"date":1685664000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":516.055,"date":1688688000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":552.05,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":556.868,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":499.45,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":455.015,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":495.231,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":531.75,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":550.488,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":575.791,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":581.61,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Thermo Fisher
                  Bio-Rad Laboratories
                  Align Tech
                  Illumina
                  Danaher

                  Best Analysts Covering 0R0H

                  1 Year
                  1 Year Success Rate
                  20/20 ratings generated profit
                  100%
                  1 Year Average Return
                  +23.49%
                  upgraded a buy rating 3 months ago
                  Copying Jack Meehan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +23.49% per trade.
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis